ADA Scientific Sessions 2025 Abstract
The High Prevalence of Metabolic Dysfunction–Associated Steatohepatitis (MASH) in People with T2D Support the Need for Screening to Prevent Future Cirrhosis
By Eddison Godinez Leiva, Andrea Ortiz Rocha, Nathaly Cuervo-Pardo, Show 10 more authorsKenneth J. Cusi
Study in peoplePopulations
The paper
Gainesville
ADA Scientific Sessions 2025 Abstract, 13 Jun 2025
Presented at ADA Scientific Sessions 2025, poster 1644-P
